Know Cancer

or
forgot password
  • cancer clinical trials in joliet, IL

  • Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Midwest Center for Hematology Oncology
    Joliet, Illinois 60432
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    Midwest Center for Hematology Oncology
    Joliet, Illinois 60432
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Joliet Oncology-Hematology Associates Limited

    Trial Locations
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
    Midwest Center for Hematology/Oncology
    Joliet, Illinois 60432
    Breast Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
    Joliet Oncology-Hematology Associates Limited
    Joliet, Illinois 60435
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Regional Transitional Cell Cancer of the Renal Pelvis and Ureter, Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer, Urethral Cancer Associated With Invasive Bladder Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Joliet Oncology-Hematology Associates Limited
    Joliet, Illinois 60435
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Midwest Center for Hematology/Oncology
    Joliet, Illinois 60432
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Joliet Oncology-Hematology Associates Limited
    Joliet, Illinois 60435
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Midwest Center for Hematology/Oncology
    Joliet, Illinois 60432
    Breast Cancer
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Joliet Oncology-Hematology Associates, Limited - West
    Joliet, Illinois 60435
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Joliet Oncology-Hematology Associates Limited

    Trial Locations
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Joliet Oncology-Hematology Associates Limited

    Trial Locations
    Joliet Oncology-Hematology Associates Limited
    Midwest Center for Hematology Oncology
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Midwest Center for Hematology Oncology
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Saint Joseph Medical Center

    Trial Locations
    Saint Joseph Medical Center
    Joliet Oncology-Hematology Associates Limited
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer